期刊文献+

三氧化二砷粉针剂联合重组腺病毒介导的IκBαM治疗肝癌 被引量:1

Inhibitory effect of As_2 O_3 combined with adenovirus carrying IκBαM on proliferation of liver cancer cells in vitro and in vivo
下载PDF
导出
摘要 目的:探讨三氧化二砷(arsenic trioxide,As2O3)粉针剂联合重组腺病毒介导的IκBαM抑制肝癌细胞增殖及对大鼠肝癌的治疗效果.方法:MTT法检测不同浓度As2O3联合Ad-IκBαM对肝癌细胞增殖的抑制作用.探讨体内As2O3联合Ad-IκBαM对二乙基亚硝胺诱发的大鼠肝癌的抑制作用,并应用TUNEL法检测各处理组肝癌的凋亡指数.结果:As2O3处理肝癌细胞SMMC-7721的细胞毒作用存在剂量依赖性以及时间依赖性,16 mol/L的As2O3抑制率最高,48、72、96 h分别为17.7%±5.3%、40.7%±2.5%、62.8%±5.4%.16 mol/L As2O3联合转染Ad-IκBαM处理组在72 h和96 h,对肝癌细胞抑制率分别为68.3%±2.1%和81.9%±3.0%,显著高于16μmol/L As2O3联合Ad-I B组(P值分别为0.004).二乙基亚硝胺于第16周诱发大鼠肝癌,成瘤率约达80%.各处理组成瘤大鼠(包括无菌生理盐水组、As2O3组、As2O3+Ad-I B组以及As2O3+Ad-IκBαM组)的生存期无明显差别.As2O3联合Ad-IκBαM处理组肝癌的凋亡率较其他处理组均显著增高.结论:腺病毒介导的IκBαM与As2O3具有协同作用,转染Ad-IκBαM可以明显增强As2O3的抑制肝癌细胞增殖作用以及体内抑瘤作用. AIM:To analyze the inhibitory effect of arsenic trioxide(As2O3) combined with adenovirus carrying IκBαM(Ad-IκBαM) on proliferation of liver cancer cells in vitro and in vivo.METHODS:The effect of As2O3 combined with Ad-IκBαM on liver cancer cell growth was assessed by MTT assay.Wistar rats were treated with diethylnitrosamine(DENA) for about 16 wk to induce liver cancer.The index of apoptosis was assessed by TUNEL assay.RESULTS:As2O3 induced cellular toxicity in a dose-and time-dependent fashion in SMMC-7721cells.MTT assay showed that the proliferation of SMMC-7721 cells was most significantly suppressed by As2O3 at a dose of 16 mol/L,and the reduced rate of cell proliferation was 17.7%±5.3%,40.7%±2.5% and 62.8%±5.4% at 48,72 and 96 h,respectively.The reduced rate of cell proliferation at 72 and 96 h in cells treated with 16 mol/L As2O3 and Ad-IκBαM was 68.3%±2.1% and 81.9%±3.0%,significantly higher than those in other groups(all P0.01).DENA treatment successfully induced tumors in rats at week 16.There was no significant difference in life span of liver cancer-bearing rats among each group.TUNEL assay demonstrated that treatment with As2O3 and Ad-IκBαM greatly enhanced apoptotic cell death.CONCLUSION:Ad-IκBαM has a synergistic effect with As2O3 in inhibiting liver cancer cell proliferation in vitro and in vivo.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第13期1159-1163,共5页 World Chinese Journal of Digestology
基金 哈尔滨市科技计划基金资助项目 No.2004AA9CS196-13~~
关键词 Ad-IκBαM 三氧化二砷 基因治疗 肝癌 Ad-IκBαM Arsenic trioxide Gene therapy Liver cancer
  • 相关文献

参考文献3

二级参考文献25

  • 1JingLIU AnningLIN.Role of JNK activation in apoptosis:Adouble-edged sword[J].Cell Research,2005,15(1):36-42. 被引量:76
  • 2刘冰熔 黄爱龙 沈鼎明.核转录因子NF-κB超抑制物IκBaM的构建 [J].中华临床实用医药杂志,2002,4:8-11.
  • 3Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J]. Cancer, 1993,71 (5) :1368.
  • 4Kiluchi A, Aoki Y, Sugaya S, et al. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor[J].Human Gene Therapy, 1999,10(9):947.
  • 5Barajas M, Mazzolini G, C, enove G, et al. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 [ J]. Hepatology, 2001,33 ( 1 ) : 52.
  • 6Greenblatt MS, Benett WP, Hollstein M, et al. Mutation in the p.53 tumor suppressor gene : Clue to cancer etiology and molecular pathogenesis[J]. Cancer Res, 1994,54(12) :4855.
  • 7Anderson SC,Johnson DE,Harris MP, et al.p.53 gene therapy in a rat model of hepatocellular carinoma: Intra-artefial delivery of a recombinant adenovirus[ J]. Clin Cancer Res, 1998,4( 11 ) : 1649.
  • 8Weiss B, Davidkova G, Zhou LW. Antisense RNA gene therapy for studying and modulating biological processes [J]. Cell Mol Life Sci,1999,55(3) :334.
  • 9Kashani-Sabet M, Scanlon KJ. Application of ribozymes to cancer gene therapyl J]. Cancer Gene Ther, 1995,2(2) ;213.
  • 10Morino F,Tokunaga T, Tsuchida T, et al. Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in ahuman hepatocellular carcinoma cell line [J]. Inc J Oncol, 2000, 17(2) :495.

共引文献65

同被引文献8

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部